The association of resting heart rate with cardiovascular, cancer and all-cause mortality. Eight year follow-up of 3527 male Israeli employees (the CORDIS Study)

European Heart Journal

Volumn 21, Issue 2, 2000, Pages 116-124

  Kristal Boneh, E ^a   Silber, H ^b,c   Harari, G ^a   Froom, P ^a,b  

^a Occupational Health and Rehabilitation Institute Israel   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c MEIR MEDICAL CENTER   (Israel)

Author keywords

Cancer; Cardiovascular disease; Epidemiology; Haematology; Heart rate; Mortality

Indexed keywords

HEMOGLOBIN; LIPID; PROTEIN;

ADULT; ANTHROPOMETRY; ARTICLE; CANCER; CARDIOVASCULAR DISEASE; DEMOGRAPHY; FOLLOW UP; HEART RATE; HUMAN; HUMAN EXPERIMENT; ISCHEMIC HEART DISEASE; ISRAEL; LEUKOCYTE COUNT; LIFESTYLE; LIPID BLOOD LEVEL; MALE; MORTALITY; NORMAL HUMAN; PREDICTION; PRIORITY JOURNAL; RISK; RISK FACTOR; SOCIOECONOMICS; THROMBOCYTE COUNT;

EID: 0033956592     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1053/euhj.1999.1741     Document Type: Article

References (52)

1. Dyer AR, Persky V, Stamler J. Heart rate as a prognostic factor for coronary heart disease and mortality: findings in three Chicago epidemiologic Studies. Am J Epidemiol. 112:1980;736-749.
2. Schroll M, Hagerup LM. Risk factors of myocardial infarction and death in man aged 50 at entry. Dan Med Bull. 24:1977;252-255.
3. Medalie JH, Kahn HA, Neufeld HN. Five-year myocardial infarction incidence. II. Association of single variables to age and birth place. J Chronic Dis. 26:1973;329-349.
4. Shurtleff D. Some characteristics related to the incidence of cardiovascular disease and death: Framingham Study, 18 year follow-up. Section 30. Kannel WB, Gordon T. The Framingham Study - an Epidemiological Investigation of the Cardiovascular Diseases. 1974;DHEW, Washington, DC.
5. Friedman GD, Klatsky AL, Siegelaub AB. Predictors of sudden cardiac death. Circulation. 5:1975;164-169.
6. Kannel WB, Kannel C, Paffenbarger RS, Cupples A. Heart rate and cardiovascular mortality: the Framingham Study. Am Heart J. 113:1987;1489-1494.
7. Gillum RF, Makuc DM, Feldman JJ. Pulse rate, coronary heart disease, and death: the NHANES I Epidemiologic Follow-up Study. Am Heart J. 121:1991;172-177.
8. Manuck SB, Garland FN. Stability of individual differences in cardiovascular reactivity: A Thirteen month follow-up. Physiol Behav. 24:1980;621-624.
9. Steinhaus AH. Chronic effects of exercise. Physiol Rev. 13:1933;103.
10. Goldbourt U, Medalie JH. Characteristics of smokers, non-smokers and ex-smokers among 10 000 adult males in Israel. II. Physiologic, biochemical and genetic characteristics. Am J Epidemiol. 105:1977;75-86.
11. Blackburn H, Brozek J, Taylor HL, Keys A. Comparison of cardiovascular and related characteristics in habitual smokers and non-smokers. Ann N Y Acad Sci. 90:1960;277-289.
12. Higgins MW, Kjelsberg M. Characteristics of smokers and non-smokers in Tecumseh, Michigan. II The distribution of selected physical measurements and physiologic variables and the prevalence of certain diseases in smokers and non-smokers. Am J Epidemiol. 86:1967;60-77.
13. Thomas CB. Characteristics of smokers compared with non-smokers in a population of healthy young adults, including observations of family history, blood pressure, heart rate, body weight, cholesterol and certain physiologic traits. Ann Intern Med. 53:1960;697-718.
14. Gillum RF. The epidemiology of resting heart rate in a national sample of men and women: associations with hypertension, coronary heart disease, blood pressure, and other cardiovascular risk factors. Am Heart J. 116:1988;163-174.
15. Haddy FJ. Local control of vascular resistance as related to hypertension. Arch Intern Med. 133:1974;916.
16. Dimsdale JE, Herd JA. Variability of plasma lipids in response to emotional arousal (review article). Psychosom Med. 44:1982;413-430.
17. Golding L. Effects of physical training upon total serum cholesterol levels. Res Quart. 32:1961;499.
18. Skinner JS, Holloszy KO, Cureton TK. Effects of a program of endurance exercises on physical work. Am J Cardiol. 14:1964;747.
19. Ohlsson O, Henningsen NC, Malmquist I. Blood pressure, heart rate and plasma albumin in relatives of hypertensive patients. Acta Med Scand. 209:1981;445-450.
20. Tibblin G, Bergrntz SE, Bjure J. Hematocrit, plasma protein, plasma volume, and viscosity in early hypertensive disease. Am Heart J. 72:1966;165-176.
21. Chang-Yeung M, Buncio AD. Leokocyte count, smoking, and lung function. Am J Med. 76:1984;31-37.
22. Friedman GD, Siegelaub AB, Seltzer CC, Feldman R, Collen MF. Smoking habits and the leukocyte count. Arch Environ Health. 26:1973;137-143.
23. Kristal-Boneh E, Harari G, Green MS. Serum lipids and haematological factors associated with resting heart rate: the CORDIS Study. J Cardio Risk. 1:1994;59-67.
24. Martin MJ, Hulley SB, Browner WS, Kuller LH, Wentworth D. Serum cholesterol, blood pressure, and mortality: implications from a cohort of 361 662 men. Lancet. ii:1986;933-936.
25. JAMA. 251:1984;365-374.
26. Phillips A, Shaper AG, Whincup PH. Association between serum albumin and mortality from cardiovascular disease, cancer and other causes. Lancet. ii:1989;1434-1436.
27. Kuller LH, Eichner JE, Orchard TJ, Grandits GA, McCallum L, Russell PT. The relation between serum albumin levels and risk of coronary heart disease in the Multiple Risk Factor Intervention Trial. Am J Epidemiol. 134:1991;1266-1277.
28. Birnbaum M. Normal hemoglobin level and coronary heart disease. Am Heart J. 62:1963;136-137.
29. Burch G, DePasquale N. Erythrocytosis and ischemic myocardial disease. Am Heart J. 62:1963;139-140.
30. Abu-Zeid HAH, Chapman JM. The relationship between hemoglobin level and some risk factors in ischemic heart disease. The Los Angeles Heart Study [abstract]. Circulation. 48:1973;9.
31. Fagher B, Sjogren A, Sjogren U. Platelet counts in myocardial infarction, angina pectoris and peripheral artery disease. Acta Med Scand. 271:1985;21-26.
32. Ensrud K, Grimm RH. The white blood cell count and risk for coronary heart disease. Am Heart J. 124:1992;207-213.
33. Thaulow E, Erikssen J, Sandvik L, Cohn PF. Blood platelet count is related to cardiovascular death in apparently healthy men [abstract]. Circulation. 80:1989;II299.
34. Wannamethee G, Shaper AG, Macfarlane PW. Heart rate, physical activity, and mortality from cancer and other noncardiovascular diseases. Am J Epidemiol. 137:1993;735-748.
35. Persky V, Dyer AR, Leonas J. Heart rate a risk factor for cancer? Am J Epidemiol. 114:1981;477-487.
36. Garcia-Palmieri MR, Sorlie PD, Costas R Jr. An apparent inverse relationship between serum cholesterol and cancer mortality in Puerto Rico. Am J Epidemiol. 114:1981;29-40.
37. Severson RK, Nomura AMY, Grove JS. A prospective analysis of physical activity and cancer. Am J Epidemiol. 130:1989;522-529.
38. Gann PH, Daviglus ML, Dyer AR, Stamler J. Heart rate and prostate cancer mortality: Results of a prospective analysis. Cancer Epidemiol Bio Prev. 4:1995;611-616.
39. Lee IM, Paffenbarger RS Jr, Hsieh CC. Physical activity and risk of prostatic cancer among college alumni. Am J Epidemiol. 135:1992;169-179.
40. Green M, Peled I. Prevalence and control of hypertension in a large cohort of occupationally-active Israelis examined during 1985-1987. The CORDIS Study. Int J Epidemiol. 21:1992;676-682.
41. Allain CC, Poon IS, Chan CSG, Richmond IY, Fu PC. Enzymatic determination of total serum cholesterol. Clin Chem. 20:1974;470-475.
42. Kristal-Boneh E, Harari G, Weinstein Y, Green MS. Factors affecting differences in supine, sitting, and standing heart rate: the Israeli CORDIS study. Aviat Space Environ Med. 66:1995;775-779.
43. SAS Institute Inc, SAS Language: Reference, Cary, NC, SAS Institute Inc.
44. Palatini P, Julius S. Heart rate and the cardiovascular risk. J Hypertens. 15:1997;3-17.
45. Julius S. Sympathetic hyperactivity and coronary risk in hypertension. Corcoran lecture. Hypertension. 21:1993;886-893.
46. Conway J. Hemodynamic aspects of essential hypertension in humans. Physiol Rev. 64:1984;617-660.
47. Ewing DJ, Campbell IW, Clarke BF. Heart rate changes in diabetes mellitus. Lancet. 1:1981;183-185.
48. Gordon D, Guyton I, Karnovsky N. Intimal alterations in rat aorta induced by stressful stimuli. Lab Invest. 45:1983;14-19.
49. Hirsch EZ, Maksem JA, Gagen D. Effects of stress and propanolol on the aortic intima of rats (Abstr). Arteriosclerosis. 4:1984;526.
50. Persky A, Hamsten A, Lindvall K, Theorell T. Heart rate correlates with severity of coronary atherosclerosis in young postinfarction patients. Am Heart J. 116:1988;1360-1373.
51. Persky A, Olsson G, London C, deFaire U, Theorell T, Hamsten A. Minimum heart rate and coronary atherosclerosis. Independent relations to global severity and rate of progression of angiographic lesions in men with myocardial infarction at a young age. Am Heart J. 123:1992;609-616.
52. Malik M, Camm J. Clinical implications and use of heart rate variability. Malik M, Camm J. Heart rate variability (part IV). 1995;331-338 Futura Pub. Comp. Inc, New York.